SALT LAKE CITY, Utah — A federal grand jury has indicted a Utah physician for allegedly distributing misbranded drugs from China to unsuspecting patients.
Justin Bradley Watkins, a 39-year-old from Pleasant View, Utah, is accused of obtaining non-FDA-approved peptides through a middleman between February 2024 and April 2025, according to court documents. The drugs included Tirzepatide, Semaglutide, Retatrutide, Cagrilinitide, BPC-157, TB500, Ipamorelin, CJC 1295, GHK, GHK-CU, and NAD+. Watkins allegedly purchased these peptides at discounted prices, aware they lacked proper testing and clinical trials.
The indictment claims Watkins labeled the drugs without disclosing the manufacturer, packer, or distributor, violating the FDA’s Food, Drug, and Cosmetic Act. Over 200 patients received these misbranded drugs, the press release stated…